1. Home
  2. WST vs BR Comparison

WST vs BR Comparison

Compare WST & BR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • BR
  • Stock Information
  • Founded
  • WST 1923
  • BR 1962
  • Country
  • WST United States
  • BR United States
  • Employees
  • WST N/A
  • BR N/A
  • Industry
  • WST Medical/Dental Instruments
  • BR Business Services
  • Sector
  • WST Health Care
  • BR Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • BR Nasdaq
  • Market Cap
  • WST 23.2B
  • BR 27.6B
  • IPO Year
  • WST N/A
  • BR 2007
  • Fundamental
  • Price
  • WST $332.77
  • BR $227.34
  • Analyst Decision
  • WST Strong Buy
  • BR Hold
  • Analyst Count
  • WST 5
  • BR 8
  • Target Price
  • WST $437.75
  • BR $226.71
  • AVG Volume (30 Days)
  • WST 494.1K
  • BR 448.0K
  • Earning Date
  • WST 02-13-2025
  • BR 01-30-2025
  • Dividend Yield
  • WST 0.25%
  • BR 1.55%
  • EPS Growth
  • WST N/A
  • BR 2.64
  • EPS
  • WST 6.74
  • BR 5.79
  • Revenue
  • WST $2,876,400,000.00
  • BR $6,498,600,000.00
  • Revenue This Year
  • WST N/A
  • BR $9.50
  • Revenue Next Year
  • WST $6.08
  • BR $5.42
  • P/E Ratio
  • WST $49.37
  • BR $39.28
  • Revenue Growth
  • WST N/A
  • BR 4.67
  • 52 Week Low
  • WST $265.00
  • BR $188.30
  • 52 Week High
  • WST $413.70
  • BR $237.96
  • Technical
  • Relative Strength Index (RSI)
  • WST 58.00
  • BR 47.29
  • Support Level
  • WST $325.33
  • BR $222.57
  • Resistance Level
  • WST $335.53
  • BR $228.09
  • Average True Range (ATR)
  • WST 7.96
  • BR 3.82
  • MACD
  • WST 0.32
  • BR -1.51
  • Stochastic Oscillator
  • WST 78.28
  • BR 30.99

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About BR Broadridge Financial Solutions Inc.

Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communications and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two segments: investor communication solutions and global technology and operations.

Share on Social Networks: